ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VIRI Virios Therapeutics Inc

0.2328
-0.1532 (-39.69%)
May 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 907,710
Bid Price 0.20
Ask Price 0.72
News (2)
Day High 0.4095

Low
0.279

52 Week Range

High
2.42

Day Low 0.3507
Company Name Stock Ticker Symbol Market Type
Virios Therapeutics Inc VIRI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1532 -39.69% 0.2328 00:00:07
Open Price Low Price High Price Close Price Prev Close
0.4095 0.3507 0.4095 0.3514 0.386
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
878 907,710 $ 0.3680598 $ 334,092 - 0.279 - 2.42
Last Trade Time Type Quantity Stock Price Currency
19:59:26 formt 770 $ 0.2328 USD

Virios Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.74M 19.26M - 0 -5.3M -0.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Virios Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VIRI Message Board. Create One! See More Posts on VIRI Message Board See More Message Board Posts

Historical VIRI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3670.43660.3350.3762913138,730-0.1342-36.57%
1 Month0.4590.47490.3350.4028903108,392-0.2262-49.28%
3 Months0.38860.62880.2790.4331042305,567-0.1558-40.09%
6 Months0.7210.940.2790.4844292267,897-0.4882-67.71%
1 Year1.032.420.2791.07458,866-0.7972-77.40%
3 Years4.709.11090.2189511.08493,824-4.47-95.05%
5 Years13.7614.390.2189511.58466,057-13.53-98.31%

Virios Therapeutics Description

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia.